Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Tuyển tập các báo cáo nghiên cứu khoa học ngành y học tạp chí Medical Sciences dành cho các bạn sinh viên ngành y tham khảo đề tài: Weight loss, leukopenia and thrombocytopenia associated with sustained virologic response to Hepatitis C treatment. | Int. J. Med. Sci. 2010 7 36 International Journal of Medical Sciences 2010 7 1 36-42 Ivyspring International Publisher. All rights reserved Research Paper Weight loss leukopenia and thrombocytopenia associated with sustained virologic response to Hepatitis C treatment Nuntra Suwantarat Alan D. TiceH Thana Khawcharoenporn Dominic C. Chow Department of Medicine John A. Burns School of Medicine University of Hawaii Honolulu Hawaii USA 96813. H Corresponding Author Alan D. Tice MD FACP. Infections Limited Hawaii 1286 Queen Emma Street Honolulu Hawaii 96813. E-mail alantice@idlinks.com Telephone 1-808-373-3488 Fax 1-808-536-2024. Co-Corresponding Author Nuntra Suwantarat MD. Department of Medicine John A. Burns School of Medicine University of Hawaii 1356 Lusitana Street 7th Floor Honolulu HI 96813. E-mail nuntra@hawaii.edu Telephone 1-808- 586-2910 Fax 1-808-586-7486 Received 2009.10.19 Accepted 2010.01.21 Published 2010.01.22 Abstract OBJECTIVE To identify apparent adverse effects of treatment of chronic hepatitis C and their relationship to sustained virologic response SVR . METHODS A retrospective study was conducted of all Hepatitis C virus HCV -infected patients treated with pegylated interferon and ribavirin in an academic ambulatory infectious disease practice. Clinical and laboratory characteristics were compared between patients with SvR and without SVR. RESULTS Fifty-four patients completed therapy with the overall SVR rate of 76 . SVR was associated with genotype non-1 P 0.01 weight loss more than 5 kilograms P 0.04 end of treatment leukopenia P 0.02 and thrombocytopenia P 0.05 . In multivariate analysis SVR was significant associated with HCV genotype non-1 Adjusted Odd Ratio AOR 15.22 CI 1.55 to 149.72 P 0.02 weight loss more than 5 kilograms AOR 5.74 CI 1.24 to 26.32 P 0.04 and end of treatment white blood cell count level less than 3 X 103 cells pl AOR 9.09 CI 1.59 to 52.63 P 0.02 . Thrombocytopenia was not significant after adjustment. Other factors .